Notch Therapeutics

Private

VancouverHealthcare & Life Scienceshttp://notchtx.com/

Last Round

M&A

Apr 2, 2025

Est. Valuation

$20M

Total Funding Raised

$90M

Company Overview

Notch Therapeutics is a biotechnology company that develops renewable, induced pluripotent stem cell (iPSC)-derived immunotherapies for cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

allogeneic cell therapyiPSCinduced pluripotent stem celloff-the-shelf CAR-TT cell therapyengineered thymic nicheETNcell engineeringoff-the-shelf therapybiotech platformCAR-Toncology therapeuticsimmunologydrug discoveryprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Notch Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Notch Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Notch Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Apr 2, 2025
Series A	Feb 10, 2021
Seed	Nov 1, 2019

View all Funding Rounds

Notch Therapeutics Investors

Notable investors and investment history

Notch Therapeutics investors
Investor	Rounds
EcoR1 Capital	Series A
Amplitude Ventures	Series A
CCRM	Series A, Seed
CCRM Enterprises Inc.	Series A
Lumira Ventures	Seed, Series A
Casdin Capital	Series A
TIAP	Seed

View all Investors

Notch Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Notch Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Notch Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver

Employee Range9

Year Founded2018

Last FundingApr 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.